ARMISTICE CAPITAL LLC 13D and 13G filings for scPharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-14 2:56 pm Sale | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | ARMISTICE CAPITAL LLC | 0 0.000% | -2,148,000![]() (Position Closed) | Filing |
2023-02-14 1:25 pm Purchase | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | ARMISTICE CAPITAL LLC | 2,148,000 6.310% | 2,148,000![]() (New Position) | Filing |